Key result
Among 34,465 older patients with NSTEMI, overweight and obese class I and II patients had lower long-term mortality compared to normal-weight patients, but similar or higher readmissions.
Why the study?
Does higher body mass index improve long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction?
Cohort (n=34,465)
Yes
Does higher body mass index improve long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction?
In older patients with NSTEMI, being overweight or mildly to moderately obese is associated with lower long-term mortality compared to normal weight, demonstrating a long-term obesity paradox.
Obesity paradox in NSTEMI may extend to 3 years; extends prior observations but remains hypothesis-generating and should not change practice.
BACKGROUND: Prior studies have found that obese patients have paradoxically lower in-hospital mortality after non-ST-segment-elevation myocardial infarction than their normal-weight counterparts, yet whether these associations persist long term is unknown. METHODS AND RESULTS: We linked detailed clinical data for patients with non-ST-segment-elevation myocardial infarction aged ≥65 years in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) Registry to Medicare claims data to obtain longitudinal outcomes. Using height and weight measured on admission, patients were categorized into 6 body mass index (BMI [kilograms per meter squared]) groups. Multivariable Cox proportional hazards models were used to estimate the association between BMI and (1) all-cause mortality, (2) all-cause readmission, (3) cardiovascular readmission, and (4) noncardiovascular readmission for 3 years after hospital discharge. Among older patients with non-ST-segment-elevation myocardial infarction (n=34,465), 36.3% were overweight and 27.7% were obese. Obese patients were younger and more likely to have hypertension, diabetes mellitus, and dyslipidemia than normal or underweight patients. Relative to normal-weight patients, long-term mortality was lower for patients classified as overweight (BMI, 25.0-29.9), obese class I (BMI, 30.0-34.9), and obese class II (BMI, 35.0-39.9), but not obese class III (BMI ≥40.0). In contrast, 3-year all-cause and cardiovascular readmission were similar across BMI categories. Relative to normal-weight patients, noncardiovascular readmissions were similar for obese class I but higher for obese class II and obese class III. CONCLUSIONS: All-cause long-term mortality was generally lower for overweight and obese older patients after non-ST-segment-elevation myocardial infarction relative to those with normal weight. Longitudinal readmissions were similar or higher with increasing BMI.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2013) conducted a cohort in Non-ST-segment-elevation myocardial infarction (n=34,465). Body mass index (overweight and obesity) vs. Normal-weight patients was evaluated on All-cause mortality, all-cause readmission, cardiovascular readmission, and noncardiovascular readmission. Among 34,465 older patients with NSTEMI, overweight and obese class I and II patients had lower long-term mortality compared to normal-weight patients, but similar or higher readmissions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: